Learn / ARTV
NASDAQ: ARTV
Artiva Biotherapeutics (ARTV) stock, explained like you're 5
Artiva Biotherapeutics trades on the Nasdaq under the ticker ARTV. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 339 million dollars.
- Ticker
- ARTV
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Small cap, about 339 million dollars
Is Artiva Biotherapeutics a small, medium or large cap company?
No. Artiva Biotherapeutics is a small cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 339 million dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Artiva Biotherapeutics makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ARTV stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Discipline and Rules Based Execution in ARTV Response (Stock Traders Daily)
- ARTV Oct 2026 12.500 call (ARTV261016C00012500) Interactive Stock Chart (Yahoo! Finance Canada)
- A cell treatment and a drug depleted antibody making immune cells in 60 people with rheumatic diseases (Stock Titan)
- Have Insiders Sold Artiva Biotherapeutics Shares Recently? (Simply Wall Street)
- ARTV Stock Price and Chart NASDAQ:ARTV (TradingView)
Follow ARTV in your daily brief
Each trading day at 5 PM ET we post what happened to Artiva Biotherapeutics and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ARTV
Questions about Artiva Biotherapeutics stock
What does Artiva Biotherapeutics do?
Artiva Biotherapeutics trades on the Nasdaq under the ticker ARTV. It is a small cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 339 million dollars.
What is the ticker symbol for Artiva Biotherapeutics?
Artiva Biotherapeutics trades under the ticker ARTV on the Nasdaq.
What is Artiva Biotherapeutics's market cap?
Artiva Biotherapeutics is a small cap stock with a market cap of about 339 million dollars.
How does Artiva Biotherapeutics make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ARTV stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ARTV stock every day?
Add ARTV to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.